Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
Tokyo Medical Team Develops Novel Scleral Imaging Technique
In a study published in the journal JAMA Ophthalmology, researchers at Tokyo Medical and Dental University (TMDU) in Japan have successfully pioneered a new optical coherence tomography (OCT) technique. This innovative method, known as polarization-sensitive OCT (PS-OCT), provides unprecedented insights…
Preventing Inherited Retinal Dystrophy with Light Control
A joint team effort led by Dr. Haruhisa Inoue, Professor in the Department of Cell Growth and Differentiation at CiRA, has established induced pluripotent stem (iPS) cells from two patients with EYS-associated retinal dystrophies (EYS-RD) and converted them into retinal…
Resin Technology Could Improve 3D Printing of Intraocular Devices
Researchers at the University of East Anglia (UEA) have developed a novel resin suitable for 3D printing intraocular devices. This pioneering innovation holds the potential to revolutionize the production of eye implants, which are crucial for cataract and refractive surgeries,…
Wayne State University Secures Grant for Diabetes Eye Study
Dr. Fu-Shin Yu, a professor of Ophthalmology, Visual and Anatomical Sciences at Wayne State University School of Medicine, has been awarded a significant grant from the National Eye Institute of the National Institutes of Health. The five-year grant, totaling $2,167,882,…
Reichert Launches Tono-Vera Tonometer with ActiView
Reichert Technologies announced the launch of the Tono-Vera Tonometer with ActiView Positioning System in the United States. This innovative handheld device is designed to provide quick, automated, and reliable intraocular pressure (IOP) measurements using rebound tonometer technology, which eliminates the…
FDA Approves Glenmark’s Ophthalmic Solution for Glaucoma
Glenmark Pharmaceuticals has received final approval by the FDA for Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution, 0.2%|0.5% for glaucoma treatment. This solution has been recognized by the FDA as bioequivalent and therapeutically equivalent to Combigan® Ophthalmic Solution, 0.2%|0.5% by…
FDA Grants De Novo Authorization for Scanly Home OCT Device
Notal Vision announced that the FDA has granted De Novo authorization for its patient self-operated Scanly Home OCT device. Designated by the FDA as a breakthrough device for patients suffering from wet age-related macular degeneration (AMD), Scanly Home OCT aims…
Generative artificial intelligence in ophthalmology – ScienceDirect.com
Generative artificial intelligence in ophthalmology ScienceDirect.com Source: Author: | Date: 2024-05-16 22:31:00 Source: Author: | Date: 2024-05-16 22:31:00
COVID-19 Found to Affect Retinal Health
The University of Missouri School of Medicine has revealed that the virus responsible for COVID-19 can penetrate the blood-retinal barrier, potentially causing long-term eye complications. The blood-retinal barrier is a crucial defense mechanism, protecting our vision from infections by preventing…
Research Proposes Ranibizumab Over Laser for ROP Treatment
A study led by a University at Buffalo researcher has the potential to revolutionize the treatment of retinopathy of prematurity (ROP), a condition that can lead to blindness in low birthweight premature infants if left untreated. Published in eClinicalMedicine, the…